Literature DB >> 20823463

Approach to the patient with an adrenal incidentaloma.

Lynnette K Nieman1.   

Abstract

Unsuspected adrenal masses, or incidentalomas, are increasingly found with the widespread use of thoracic and abdominal imaging. These masses may be hormonally active or nonfunctional and malignant or benign. Clinicians must determine the nature of the mass to decide what treatment, if any, is needed. Measurement of precontrast Hounsfield units (HU) and contrast washout on computed tomography scan provide useful diagnostic information. All patients should undergo biochemical testing for pheochromocytoma, either with plasma or urinary catecholamine measurements. This is particularly important before surgical resection, which is routinely recommended for masses larger than 4 cm in diameter without a clear-cut diagnosis and for others with hormonal secretion or ominous imaging characteristics. Hypertensive patients should undergo biochemical testing for hyperaldosteronism. Patients with features consistent with Cushing's syndrome, such as glucose intolerance, weight gain, and unexplained osteopenia, should be evaluated for cortisol excess. Here, the dexamethasone suppression test and late-night salivary cortisol may be preferred over measurement of urine cortisol. The ability of surgical resection to reverse features of mild hypercortisolism is not well established. For masses that appear to be benign (<10 HU; washout, >50%), small (<3 cm), and completely nonfunctioning, imaging and biochemical reevaluation (pheochromocytoma and hypercortisolism only) at 1-2 yr (or more) is appropriate. For more indeterminate lesions, repeat evaluation for growth after 3-12 months is useful, with subsequent testing intervals based on the rate of growth.

Entities:  

Mesh:

Year:  2010        PMID: 20823463      PMCID: PMC2936073          DOI: 10.1210/jc.2010-0457

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  49 in total

1.  Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

Authors:  R Rossi; L Tauchmanova; A Luciano; M Di Martino; C Battista; L Del Viscovo; V Nuzzo; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

2.  Change in adrenal mass size as a predictor of a malignant tumor.

Authors:  Kevin M Pantalone; Thottathil Gopan; Erick M Remer; Charles Faiman; Adriana G Ioachimescu; Howard S Levin; Allan Siperstein; Eren Berber; Laura B Shepardson; Emmanuel L Bravo; Amir H Hamrahian
Journal:  Endocr Pract       Date:  2010 Jul-Aug       Impact factor: 3.443

3.  Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.

Authors:  C S Peña; G W Boland; P F Hahn; M J Lee; P R Mueller
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

4.  The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection.

Authors:  S Midorikawa; H Sanada; S Hashimoto; T Suzuki; T Watanabe
Journal:  Clin Endocrinol (Oxf)       Date:  2001-06       Impact factor: 3.478

5.  Computed tomography in the diagnosis of adrenal disease.

Authors:  M Korobkin; E A White; H Y Kressel; A A Moss; J P Montagne
Journal:  AJR Am J Roentgenol       Date:  1979-02       Impact factor: 3.959

6.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

Authors:  F Mantero; M Terzolo; G Arnaldi; G Osella; A M Masini; A Alì; M Giovagnetti; G Opocher; A Angeli
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.

Authors:  G G Garrapa; P Pantanetti; G Arnaldi; F Mantero; E Faloia
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

8.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

9.  Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes.

Authors:  Rifat Emral; Ali Riza Uysal; Mehmet Asik; Sevim Gullu; Demet Corapcioglu; Vedia Tonyukuk; Gurbuz Erdogan
Journal:  Endocr J       Date:  2003-08       Impact factor: 2.349

10.  Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study.

Authors:  B Bülow; B Ahrén
Journal:  J Intern Med       Date:  2002-09       Impact factor: 8.989

View more
  71 in total

1.  Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.

Authors:  A J Turner; P E Hick
Journal:  Biochem Pharmacol       Date:  1975-09-15       Impact factor: 5.858

2.  Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation.

Authors:  G Tirabassi; B Kola; M Ferretti; R Papa; T Mancini; F Mantero; M Scarpelli; M Boscaro; G Arnaldi
Journal:  J Endocrinol Invest       Date:  2011-10-04       Impact factor: 4.256

3.  Evolution of computed tomography-detectable adrenal nodules in patients with bilateral primary aldosteronism.

Authors:  Paolo Mulatero; Jacopo Burrello; Barbara Lucatello; Gilberta Giacchetti; Marialberta Battocchio; Francesco Fallo
Journal:  Endocrine       Date:  2015-12-08       Impact factor: 3.633

4.  Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.

Authors:  Serkan Yener; Leyla Demir; Mustafa Demirpence; Mustafa Mahmut Baris; Ilgin Yildirim Simsir; Secil Ozisik; Abdurrahman Comlekci; Tevfik Demir
Journal:  Endocrine       Date:  2017-02-28       Impact factor: 3.633

Review 5.  Interventional radiology of the adrenal glands: current status.

Authors:  Anna Maria Ierardi; Mario Petrillo; Francesca Patella; Pierpaolo Biondetti; Enrico Maria Fumarola; Salvatore Alessio Angileri; Filippo Pesapane; Antonio Pinto; Gianlorenzo Dionigi; Gianpaolo Carrafiello
Journal:  Gland Surg       Date:  2018-04

6.  Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma.

Authors:  Gianluca Iacobellis; Luigi Petramala; Giuseppe Barbaro; Atil Y Kargi; Valentina Serra; Laura Zinnamosca; Luciano Colangelo; Cristiano Marinelli; Antonio Ciardi; Giorgio De Toma; Claudio Letizia
Journal:  Endocrine       Date:  2013-02-21       Impact factor: 3.633

7.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Authors:  Joanne H Heaton; Michelle A Wood; Alex C Kim; Lorena O Lima; Ferdous M Barlaskar; Madson Q Almeida; Maria C B V Fragoso; Rork Kuick; Antonio M Lerario; Derek P Simon; Ibere C Soares; Elisabeth Starnes; Dafydd G Thomas; Ana C Latronico; Thomas J Giordano; Gary D Hammer
Journal:  Am J Pathol       Date:  2012-07-15       Impact factor: 4.307

8.  Low investigation rate for adrenal incidentalomas.

Authors:  S Bujawansa; D Bowen-Jones
Journal:  Endocrine       Date:  2011-05-12       Impact factor: 3.633

9.  A Web Application for Adrenal Incidentaloma Identification, Tracking, and Management Using Machine Learning.

Authors:  Wasif Bala; Jackson Steinkamp; Timothy Feeney; Avneesh Gupta; Abhinav Sharma; Jake Kantrowitz; Nicholas Cordella; James Moses; Frederick Thurston Drake
Journal:  Appl Clin Inform       Date:  2020-09-16       Impact factor: 2.342

Review 10.  [Adrenal incidentaloma : Diagnostic and therapeutic concept from an endocrinological perspective].

Authors:  N Unger
Journal:  Chirurg       Date:  2019-01       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.